BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boyer TD, Haskal ZJ;  American Association for the Study of Liver Diseases. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009. Hepatology. 2010;51:306. [PMID: 19902484 DOI: 10.1002/hep.23383] [Cited by in Crossref: 339] [Cited by in F6Publishing: 253] [Article Influence: 30.8] [Reference Citation Analysis]
Number Citing Articles
1 Yao X, Zhou H, Huang S, Tang SH, Qin JP. Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis. World J Clin Cases. 2021;9:1532-1542. [PMID: 33728297 DOI: 10.12998/wjcc.v9.i7.1532] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bhogal HK, Sanyal AJ. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol. 2011;9:936-946; quiz e123. [PMID: 21699820 DOI: 10.1016/j.cgh.2011.06.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
3 Bai M, Qi XS, Yang ZP, Yang M, Fan DM, Han GH. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis. World J Gastroenterol. 2014;20:2704-2714. [PMID: 24627607 DOI: 10.3748/wjg.v20.i10.2704] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
4 Khan F, Mehrzad H, Tripathi D. Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective. J Transl Int Med. 2018;6:97-104. [PMID: 30425945 DOI: 10.2478/jtim-2018-0022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Wang T, Liang F, Zhou Z, Qi X. Global sensitivity analysis of hepatic venous pressure gradient (HVPG) measurement with a stochastic computational model of the hepatic circulation. Computers in Biology and Medicine 2018;97:124-36. [DOI: 10.1016/j.compbiomed.2018.04.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
6 Shah KY, Gaba RC. Transjugular Intrahepatic Portosystemic Shunt Creation in Patients with Hepatocellular Carcinoma and Bleeding Gastric Varices: More Data, More Questions. J Vasc Interv Radiol 2021;32:971-3. [PMID: 34210483 DOI: 10.1016/j.jvir.2021.05.011] [Reference Citation Analysis]
7 Lakhoo J, Bui JT, Zivin SP, Lokken RP, Minocha J, Ray CE, Gaba RC. Root Cause Analysis of Rebleeding Events following Transjugular Intrahepatic Portosystemic Shunt Creation for Variceal Hemorrhage. Journal of Vascular and Interventional Radiology 2015;26:1444-53. [DOI: 10.1016/j.jvir.2015.07.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
8 Qi X, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature. Hepatol Int. 2012;6:576-590. [PMID: 26201472 DOI: 10.1007/s12072-011-9324-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
9 Lv Y, Fan D. Hepatopulmonary Syndrome. Dig Dis Sci. 2015;60:1914-1923. [PMID: 25732713 DOI: 10.1007/s10620-015-3593-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
10 Koh C, Zhao X, Samala N, Sakiani S, Liang TJ, Talwalkar JA. AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations. Hepatology 2013;58:2142-52. [PMID: 23775835 DOI: 10.1002/hep.26578] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
11 Triantafyllou T, Aggarwal P, Gupta E, Svetanoff WJ, Bhirud DP, Singhal S. Polytetrafluoroethylene-Covered Stent Graft Versus Bare Stent in Transjugular Intrahepatic Portosystemic Shunt: Systematic Review and Meta-Analysis. J Laparoendosc Adv Surg Tech A 2018;28:867-79. [PMID: 29356589 DOI: 10.1089/lap.2017.0560] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
12 Buechter M, Manka P, Gerken G, Canbay A, Blomeyer S, Wetter A, Altenbernd J, Kahraman A, Theysohn JM. Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience. Dig Dis 2018;36:218-27. [PMID: 29316565 DOI: 10.1159/000486030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
13 Lauermann J, Potthoff A, Mc Cavert M, Marquardt S, Vaske B, Rosenthal H, von Hahn T, Wacker F, Meyer BC, Rodt T. Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device. Cardiovasc Intervent Radiol 2016;39:547-56. [DOI: 10.1007/s00270-015-1209-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
14 Peter P, Andrej Z, Katarina SP, Manca G, Pavel S. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with recurrent variceal hemorrhage. Gastroenterol Res Pract. 2013;2013:398172. [PMID: 23606833 DOI: 10.1155/2013/398172] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
15 Qi X, Tian Y, Zhang W, Yang Z, Guo X. Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials. Therap Adv Gastroenterol 2017;10:32-41. [PMID: 28286557 DOI: 10.1177/1756283X16671286] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
16 Buechter M, Manka P, Theysohn JM, Reinboldt M, Canbay A, Kahraman A. Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation. Dig Liver Dis. 2018;50:54-60. [PMID: 29102174 DOI: 10.1016/j.dld.2017.09.138] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
17 Majdalany BS, Elliott ED, Michaels AJ, Hanje AJ, Saad WEA. Radiofrequency Wire Recanalization of Chronically Thrombosed TIPS. Cardiovasc Intervent Radiol 2016;39:1040-4. [DOI: 10.1007/s00270-016-1305-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tsauo J, Weng N, Ma H, Jiang M, Zhao H, Li X. Role of Transjugular Intrahepatic Portosystemic Shunts in the Management of Hepatopulmonary Syndrome: A Systemic Literature Review. J Vasc Interv Radiol. 2015;26:1266-1271. [PMID: 26074026 DOI: 10.1016/j.jvir.2015.04.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
19 Pomier-Layrargues G, Bouchard L, Lafortune M, Bissonnette J, Guérette D, Perreault P. The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status. Int J Hepatol. 2012;2012:167868. [DOI: 10.1155/2012/167868] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
20 Di Giorgio A, Agazzi R, Alberti D, Colledan M, D’antiga L. Feasibility and Efficacy of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Children. Journal of Pediatric Gastroenterology & Nutrition 2012;54:594-600. [DOI: 10.1097/mpg.0b013e3182490c05] [Cited by in Crossref: 43] [Cited by in F6Publishing: 5] [Article Influence: 4.8] [Reference Citation Analysis]
21 Teng D, Zuo H, Liu L, Dong J, Ding L. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment. Virol J. 2018;15:151. [PMID: 30285813 DOI: 10.1186/s12985-018-1067-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
22 Riggio O, Ridola L, Lucidi C, Angeloni S. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines? Dig Liver Dis. 2010;42:462-467. [PMID: 20036625 DOI: 10.1016/j.dld.2009.11.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
23 Schindler P, Seifert L, Masthoff M, Riegel A, Köhler M, Wilms C, Schmidt HH, Heinzow H, Wildgruber M. TIPS Modification in the Management of Shunt-Induced Hepatic Encephalopathy: Analysis of Predictive Factors and Outcome with Shunt Modification. J Clin Med 2020;9:E567. [PMID: 32092979 DOI: 10.3390/jcm9020567] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
24 Pinter SZ, Rubin JM, Kripfgans OD, Novelli PM, Vargas-Vila M, Hall AL, Fowlkes JB. Volumetric blood flow in transjugular intrahepatic portosystemic shunt revision using 3-dimensional Doppler sonography. J Ultrasound Med 2015;34:257-66. [PMID: 25614399 DOI: 10.7863/ultra.34.2.257] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
25 Fritz JS, Fallon MB, Kawut SM. Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med. 2013;187:133-143. [PMID: 23155142 DOI: 10.1164/rccm.201209-1583ci] [Cited by in Crossref: 60] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
26 Voron T, Romain B, Bergeat D, Véziant J, Gagnière J, Le Roy B, Pasquer A, Eveno C, Gaujoux S, Pezet D, Gronnier C; sous l’égide de l’Association française de chirurgie (AFC)., Collaborateurs (relecteurs). Surgical management of gastric adenocarcinoma. Official expert recommendations delivered under the aegis of the French Association of Surgery (AFC). J Visc Surg 2020;157:117-26. [PMID: 32151595 DOI: 10.1016/j.jviscsurg.2020.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Trivedi PS, Jensen AM, Kriss MS, Brown MA, Morgan RL, Lindrooth RC, Ho PM, Ryu RK. Ethnoracial Disparity in Hospital Survival following Transjugular Intrahepatic Portosystemic Shunt Creation for Acute Variceal Bleeding in the United States. J Vasc Interv Radiol 2021;32:941-949.e3. [PMID: 33901695 DOI: 10.1016/j.jvir.2021.02.027] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Chetcuti Zammit S, Sidhu R. Systemic manifestations - do not forget the small bowel. Curr Opin Gastroenterol 2021;37:234-44. [PMID: 33606400 DOI: 10.1097/MOG.0000000000000717] [Reference Citation Analysis]
29 Satapathy SK, Sanyal AJ. Nonendoscopic management strategies for acute esophagogastric variceal bleeding. Gastroenterol Clin North Am 2014;43:819-33. [PMID: 25440928 DOI: 10.1016/j.gtc.2014.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
30 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460. [PMID: 29653741 DOI: 10.1016/j.jhep.2018.03.024] [Cited by in Crossref: 660] [Cited by in F6Publishing: 447] [Article Influence: 220.0] [Reference Citation Analysis]
31 Danziger J, Thummalakunta L, Nelson R, Faintuch S. The risk of acute kidney injury with transjugular intrahepatic portosystemic shunts. J Nephrol 2015;28:725-8. [DOI: 10.1007/s40620-015-0187-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Tabchouri N, Barbier L, Menahem B, Perarnau J, Muscari F, Fares N, D’alteroche L, Valette P, Dumortier J, Alves A, Lubrano J, Bureau C, Salamé E. Original Study: Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhotic Patients. J Gastrointest Surg 2019;23:2383-90. [DOI: 10.1007/s11605-018-4053-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
33 Asrani SK, Asrani NS, Freese DK, Phillips SD, Warnes CA, Heimbach J, Kamath PS. Congenital heart disease and the liver. Hepatology 2012;56:1160-9. [DOI: 10.1002/hep.25692] [Cited by in Crossref: 132] [Cited by in F6Publishing: 94] [Article Influence: 14.7] [Reference Citation Analysis]
34 Roldán-Alzate A, Francois CJ, Wieben O, Reeder SB. Emerging Applications of Abdominal 4D Flow MRI. AJR Am J Roentgenol 2016;207:58-66. [PMID: 27187681 DOI: 10.2214/AJR.15.15995] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 4.4] [Reference Citation Analysis]
35 Benten D, Schulze zur Wiesch J, Sydow K, Koops A, Buggisch P, Böger RH, Gaydos CA, Won H, Franco V, Lohse AW, Ray SC, Balagopal A. The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS). BMC Gastroenterol 2011;11:107. [PMID: 21978390 DOI: 10.1186/1471-230X-11-107] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
36 Liu K, Fan XX, Wang XL, He CS, Wu XJ. Delayed liver laceration following transjugular intrahepatic portosystemic shunt for portal hypertension. World J Gastroenterol. 2012;18:7405-7408. [PMID: 23326153 DOI: 10.3748/wjg.v18.i48.7405] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
37 Gaba R, Parvinian A, Casadaban L, Couture P, Zivin S, Lakhoo J, Minocha J, Ray C, Knuttinen M, Bui J. Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis. Clinical Radiology 2015;70:e51-7. [DOI: 10.1016/j.crad.2015.02.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
38 Smith M, Durham J. Evolving Indications for Tips. Tech Vasc Interv Radiol 2016;19:36-41. [PMID: 26997087 DOI: 10.1053/j.tvir.2016.01.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
39 Brannelly NT, Hamilton-Shield JP, Killard AJ. The Measurement of Ammonia in Human Breath and its Potential in Clinical Diagnostics. Crit Rev Anal Chem 2016;46:490-501. [PMID: 26907707 DOI: 10.1080/10408347.2016.1153949] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 5.2] [Reference Citation Analysis]
40 Yang Z, Han G, Wu Q, Ye X, Jin Z, Yin Z, Qi X, Bai M, Wu K, Fan D. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol. 2010;25:1718-1725. [PMID: 21039832 DOI: 10.1111/j.1440-1746.2010.06400.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 70] [Article Influence: 8.4] [Reference Citation Analysis]
41 Modha K, Kapoor B, Lopez R, Sands MJ, Carey W. Symptomatic Heart Failure After Transjugular Intrahepatic Portosystemic Shunt Placement: Incidence, Outcomes, and Predictors. Cardiovasc Intervent Radiol. 2018;41:564-571. [PMID: 29181605 DOI: 10.1007/s00270-017-1848-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
42 Yan X, Fan C, Ma J, Li J, Dong D, Wang H, Ma F, Zheng X, Lv Y. Portacaval shunt established in six dogs using magnetic compression technique. PLoS One. 2013;8:e76873. [PMID: 24098809 DOI: 10.1371/journal.pone.0076873] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
43 Casadaban LC, Gaba RC. Percutaneous Portosystemic Shunts: TIPS and Beyond. Semin Intervent Radiol 2014;31:227-34. [PMID: 25177082 DOI: 10.1055/s-0034-1382789] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
44 Erly B, Carey WD, Kapoor B, McKinney JM, Tam M, Wang W. Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options. Semin Intervent Radiol. 2015;32:445-454. [PMID: 26622108 DOI: 10.1055/s-0035-1564794] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
45 Basit SA, Stone CD, Gish R. Portal vein thrombosis. Clin Liver Dis. 2015;19:199-221. [PMID: 25454305 DOI: 10.1016/j.cld.2014.09.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
46 Barbier L, Hardwigsen J, Borentain P, Biance N, Daghfous A, Louis G, Botta-Fridlund D, Le Treut YP. Impact of transjugular intrahepatic portosystemic shunting on liver transplantation: 12-year single-center experience. Clin Res Hepatol Gastroenterol. 2014;38:155-163. [PMID: 24183545 DOI: 10.1016/j.clinre.2013.09.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
47 Yao X, Huang S, Zhou H, Tang S, Qin J. Clinical efficacy of antiviral therapy in patients with hepatitis B-related cirrhosis after transjugular intrahepatic portosystemic shunt. WJG 2021;27:5088-99. [DOI: 10.3748/wjg.v27.i30.5088] [Reference Citation Analysis]
48 Choi JW, Kim H, Jae HJ, Jung H, Hur S, Lee M, Chung JW. Transcatheter Embolotherapy with N-Butyl Cyanoacrylate for Ectopic Varices. Cardiovasc Intervent Radiol 2015;38:344-51. [DOI: 10.1007/s00270-014-0943-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
49 Wang CM, Li X, Fu J, Luan JY, Li TR, Zhao J, Dong GX. Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis. Chin Med J (Engl) 2016;129:1261-7. [PMID: 27231160 DOI: 10.4103/0366-6999.182830] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
50 Wong K, Ozeki K, Kwong A, Patel BN, Kwo P. The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancer. PLoS One 2018;13:e0208233. [PMID: 30592722 DOI: 10.1371/journal.pone.0208233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
51 Qin JP, Tang SH, Jiang MD, He QW, Chen HB, Yao X, Zeng WZ, Gu M. Contrast enhanced computed tomography and reconstruction of hepatic vascular system for transjugular intrahepatic portal systemic shunt puncture path planning. World J Gastroenterol. 2015;21:9623-9629. [PMID: 26327770 DOI: 10.3748/wjg.v21.i32.9623] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
52 Liu J, Ma J, Yang C, Ye T, Meng J, Shi Q, Xiong B. Impact of TIPS on Splenic Volume and Thrombocytopenia. AJR Am J Roentgenol 2021;216:698-703. [PMID: 33439047 DOI: 10.2214/AJR.20.22958] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
53 Shreve L, Lee EW. Role of Interventional Radiology in Complications of Portal Hypertension. Journal of Clinical Gastroenterology 2019;53:342-9. [DOI: 10.1097/mcg.0000000000001180] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Perez I, Bolte FJ, Bigelow W, Dickson Z, Shah NL. Step by Step: Managing the Complications of Cirrhosis. Hepat Med 2021;13:45-57. [PMID: 34079394 DOI: 10.2147/HMER.S278032] [Reference Citation Analysis]
55 Adlakha N, Russo MW. Outcomes After Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients 70 Years and Older. J Clin Med. 2020;9. [PMID: 32023959 DOI: 10.3390/jcm9020381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Parker R. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Clin Liver Dis. 2014;18:319-334. [PMID: 24679497 DOI: 10.1016/j.cld.2013.12.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
57 Hong R, Dhanani RS, Louie JD, Sze DY. Intravascular ultrasound-guided mesocaval shunt creation in patients with portal or mesenteric venous occlusion. J Vasc Interv Radiol. 2012;23:136-141. [PMID: 22221479 DOI: 10.1016/j.jvir.2011.09.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
58 Campos-Varela I, Castells L, Dopazo C, Pérez-Lafuente M, Allende H, Len O, Llopart L, Vargas V, Charco R. Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature. Liver Transpl 2012;18:201-5. [PMID: 21656652 DOI: 10.1002/lt.22351] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
59 Hüsing-Kabar A, Meister T, Köhler M, Domschke W, Kabar I, Wilms C, Hild B, Schmidt HH, Heinzow HS. Is de novo hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt increased? United European Gastroenterol J 2018;6:413-21. [PMID: 29774155 DOI: 10.1177/2050640617732886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
60 Tapper EB, Jiang ZG, Patwardhan VR. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy. Mayo Clin Proc. 2015;90:646-658. [PMID: 25865476 DOI: 10.1016/j.mayocp.2015.03.003] [Cited by in Crossref: 80] [Cited by in F6Publishing: 57] [Article Influence: 13.3] [Reference Citation Analysis]
61 Nwawka OK, Bathala T, Kabutey N, Kim D. Simple Technique for Transjugular Intrahepatic Portosystemic Shunt Reduction Using a Flared Stent Graft. Journal of Vascular and Interventional Radiology 2012;23:1251-3. [DOI: 10.1016/j.jvir.2012.06.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
62 Chen H, Bai M, Qi X, Liu L, He C, Yin Z, Fan D, Han G. Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS. PLoS One 2013;8:e79637. [PMID: 24244533 DOI: 10.1371/journal.pone.0079637] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
63 Parekh PJ, Buerlein RC, Shams R, Vingan H, Johnson DA. Evaluation of gastrointestinal bleeding: Update of current radiologic strategies. World J Gastrointest Pharmacol Ther 2014;5:200-8. [PMID: 25374760 DOI: 10.4292/wjgpt.v5.i4.200] [Cited by in CrossRef: 3] [Article Influence: 0.4] [Reference Citation Analysis]
64 Valdivieso A, Ventoso A, Gastaca M, Bustamante J, Aguinaga A, Ruiz P, Gonzalez-uriarte J, Martínez-indart L, Testillano M, Fernández J, Muñoz F, Montejo M, Matarranz A, Suárez M, Ortiz de Urbina J. Does the Transjugular Intrahepatic Portosystemic Influence the Outcome of Liver Transplantation? Transplantation Proceedings 2012;44:1505-7. [DOI: 10.1016/j.transproceed.2012.05.070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
65 Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, Sitbon O, Sokol RJ. International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation. 2016;100:1440-1452. [PMID: 27326810 DOI: 10.1097/tp.0000000000001229] [Cited by in Crossref: 161] [Cited by in F6Publishing: 36] [Article Influence: 40.3] [Reference Citation Analysis]
66 Han G, Qi X, He C, Yin Z, Wang J, Xia J, Yang Z, Bai M, Meng X, Niu J, Wu K, Fan D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol. 2011;54:78-88. [PMID: 20932597 DOI: 10.1016/j.jhep.2010.06.029] [Cited by in Crossref: 144] [Cited by in F6Publishing: 119] [Article Influence: 13.1] [Reference Citation Analysis]
67 Chen ZJ, Freeman ML. Management of upper gastrointestinal bleeding emergencies: evidence-based medicine and practical considerations. World J Emerg Med 2011;2:5-12. [PMID: 25214975 DOI: 10.5847/wjem.j.1920-8642.2011.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
68 Vipani A, Lindenmeyer CC, Sundaram V. Treatment of Severe Acute on Chronic Liver Failure: Management of Organ Failures, Investigational Therapeutics, and the Role of Liver Transplantation. J Clin Gastroenterol 2021;55:667-76. [PMID: 34028394 DOI: 10.1097/MCG.0000000000001568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Tsauo J, Luo X, Ye L, Li X. Three-Dimensional Path Planning Software-Assisted Transjugular Intrahepatic Portosystemic Shunt: A Technical Modification. Cardiovasc Intervent Radiol 2015;38:742-6. [DOI: 10.1007/s00270-014-0931-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
70 Farsad K, Kolbeck KJ, Keller FS, Barton RE, Kaufman JA. Primary creation of an externally constrained TIPS: a technique to control reduction of the portosystemic gradient. AJR Am J Roentgenol 2015;204:868-71. [PMID: 25794080 DOI: 10.2214/AJR.14.13104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715-735. [PMID: 25042402 DOI: 10.1002/hep.27210] [Cited by in Crossref: 879] [Cited by in F6Publishing: 615] [Article Influence: 125.6] [Reference Citation Analysis]
72 Gangireddy VG, Kanneganti PC, Sridhar S, Talla S, Coleman T. Management of thrombocytopenia in advanced liver disease. Can J Gastroenterol Hepatol. 2014;28:558-564. [PMID: 25222481 DOI: 10.1155/2014/532191] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
73 Tan H, Martin P. Care of the Liver Transplant Candidate. Clinics in Liver Disease 2011;15:779-806. [DOI: 10.1016/j.cld.2011.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
74 Saad WE, Sze DY. Variations of Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Balloon-occluded Antegrade Transvenous Obliteration (BATO) and Alternative/Adjunctive Routes for BRTO. Semin Intervent Radiol 2011;28:314-24. [PMID: 22942549 DOI: 10.1055/s-0031-1284458] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
75 Riggio O, Nardelli S, Moscucci F, Pasquale C, Ridola L, Merli M. Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt. Clinics in Liver Disease 2012;16:133-46. [DOI: 10.1016/j.cld.2011.12.008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 8.3] [Reference Citation Analysis]
76 Khabbaz RC, Lokken RP, Chen YF, Lipnik AJ, Bui JT, Ray CE Jr, Gaba RC. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Do Not Predict Survival After Transjugular Intrahepatic Portosystemic Shunt Creation. Cardiovasc Intervent Radiol 2018;41:1029-34. [PMID: 29516241 DOI: 10.1007/s00270-018-1923-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
77 Luo X, Ye L, Zhou X, Tsauo J, Zhou B, Zhang H, Zhang X, Li X. C-Arm Cone-Beam Volume CT in Transjugular Intrahepatic Portosystemic Shunt: Initial Clinical Experience. Cardiovasc Intervent Radiol. 2015;38:1627-1631. [PMID: 25832762 DOI: 10.1007/s00270-015-1087-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
78 Huang L, Yu QS, Zhang Q, Liu JD, Wang Z. Transjugular intrahepatic portosystemic shunt versus surgical shunting in the management of portal hypertension. Chin Med J (Engl) 2015;128:826-34. [PMID: 25758281 DOI: 10.4103/0366-6999.152676] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Trivedi PS, Rochon PJ, Durham JD, Ryu RK. National Trends and Outcomes of Transjugular Intrahepatic Portosystemic Shunt Creation Using the Nationwide Inpatient Sample. Journal of Vascular and Interventional Radiology 2016;27:838-45. [DOI: 10.1016/j.jvir.2015.12.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
80 Liu J, Shi Q, Xiao S, Zhou C, Zhou B, Yuan F, Zheng C, Lin S, Qian K, Feng G, Xiong B. Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage. J Gastroenterol Hepatol 2020;35:278-83. [PMID: 31222830 DOI: 10.1111/jgh.14761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Ede CJ, Nikolova D, Brand M. Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis. Cochrane Database Syst Rev 2018;8:CD011717. [PMID: 30073663 DOI: 10.1002/14651858.CD011717.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
82 Luo X, Wang X, Zhu Y, Xi X, Zhao Y, Yang J, Li X, Yang L. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm. Cardiovasc Intervent Radiol 2019;42:737-43. [DOI: 10.1007/s00270-019-02162-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
83 Luo X, Nie L, Tsauo J, Wang Z, Tang C, Li X. Parallel shunt for the treatment of transjugular intrahepatic portosystemic shunt dysfunction. Korean J Radiol. 2013;14:423-429. [PMID: 23690708 DOI: 10.3348/kjr.2013.14.3.423.pmc3655295] [Reference Citation Analysis]
84 Luo X, Wang X, Zhao Y, Ma H, Ye L, Yang L, Tsauo J, Jiang M, Li X. Real-Time 3D CT Image Guidance for Transjugular Intrahepatic Portosystemic Shunt Creation Using Preoperative CT: A Prospective Feasibility Study of 20 Patients. AJR Am J Roentgenol 2017;208:W11-6. [PMID: 27786554 DOI: 10.2214/AJR.15.15210] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
85 Jain D, Mahmood E, V-Bandres M, Feyssa E. Preoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal surgery. Ann Gastroenterol 2018;31:330-7. [PMID: 29720858 DOI: 10.20524/aog.2018.0249] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Richter J, Bode JG, Blondin D, Kircheis G, Kubitz R, Holtfreter MC, Müller-Stöver I, Breuer M, Hüttig F, Antoch G, Häussinger D. Severe liver fibrosis caused by Schistosoma mansoni: management and treatment with a transjugular intrahepatic portosystemic shunt. Lancet Infect Dis 2015;15:731-7. [PMID: 25769268 DOI: 10.1016/S1473-3099(15)70009-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
87 Pereira K, Baker R, Salsamendi J, Doshi M, Kably I, Bhatia S. An Approach to Endovascular and Percutaneous Management of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Dysfunction: A Pictorial Essay and Clinical Practice Algorithm. Cardiovasc Intervent Radiol 2016;39:639-51. [DOI: 10.1007/s00270-015-1247-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
88 Zhao JR, Wang GC, Hu JH, Zhang CQ. Risk factors for early rebleeding and mortality in acute variceal hemorrhage. World J Gastroenterol 2014;20:17941-8. [PMID: 25548492 DOI: 10.3748/wjg.v20.i47.17941] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
89 Ballester MP, Lluch P, Tosca J, Capilla M, Gómez C, Moreno O, Jordán-Iborra C, Sunsundegui P, Argemi J, Guijarro J, Mínguez M. Serum cholesterol predicts transplant-free survival in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt. Dig Liver Dis 2021:S1590-8658(21)00220-6. [PMID: 34052179 DOI: 10.1016/j.dld.2021.04.035] [Reference Citation Analysis]
90 Wannhoff A, Hippchen T, Weiss CS, Friedrich K, Rupp C, Neumann-Haefelin C, Dollinger M, Antoni C, Stampfl U, Schemmer P, Stremmel W, Weiss KH, Radeleff B, Katus HA, Gotthardt DN. Cardiac volume overload and pulmonary hypertension in long-term follow-up of patients with a transjugular intrahepatic portosystemic shunt. Aliment Pharmacol Ther. 2016;43:955-965. [PMID: 26919285 DOI: 10.1111/apt.13569] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
91 Krajina A, Hulek P, Fejfar T, Valek V. Quality improvement guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS). Cardiovasc Intervent Radiol. 2012;35:1295-1300. [PMID: 23070105 DOI: 10.1007/s00270-012-0493-y] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
92 Gaba RC. Transjugular Intrahepatic Portosystemic Shunt Creation With Embolization or Obliteration for Variceal Bleeding. Techniques in Vascular and Interventional Radiology 2016;19:21-35. [DOI: 10.1053/j.tvir.2016.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
93 Gur I, Diggs BS, Orloff SL. Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant. HPB (Oxford). 2014;16:481-493. [PMID: 23961811 DOI: 10.1111/hpb.12163] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
94 Dissegna D, Sponza M, Falleti E, Fabris C, Vit A, Angeli P, Piano S, Cussigh A, Cmet S, Toniutto P. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2019;31:626-632. [PMID: 30550458 DOI: 10.1097/meg.0000000000001342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
95 Patidar KR, Sydnor M, Sanyal AJ. Transjugular intrahepatic portosystemic shunt. Clin Liver Dis 2014;18:853-76. [PMID: 25438287 DOI: 10.1016/j.cld.2014.07.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
96 Saab S, Kim NG, Lee EW. Practical Tips on TIPS: When and When Not to Request It. Am J Gastroenterol 2020;115:797-800. [PMID: 32427674 DOI: 10.14309/ajg.0000000000000611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Baiges A, Hernández-Gea V, Bosch J. Pharmacologic prevention of variceal bleeding and rebleeding. Hepatol Int 2018;12:68-80. [PMID: 29210030 DOI: 10.1007/s12072-017-9833-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
98 Bannas P, Roldán-Alzate A, Johnson KM, Woods MA, Ozkan O, Motosugi U, Wieben O, Reeder SB, Kramer H. Longitudinal Monitoring of Hepatic Blood Flow before and after TIPS by Using 4D-Flow MR Imaging. Radiology 2016;281:574-82. [PMID: 27171019 DOI: 10.1148/radiol.2016152247] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
99 Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol 2017;9:603-12. [PMID: 28515846 DOI: 10.4254/wjh.v9.i12.603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
100 Bercu ZL, Fischman AM, Kim E, Nowakowski FS, Patel RS, Schiano TD, Chang CY, Lookstein RA. TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts. AJR Am J Roentgenol. 2015;204:654-661. [PMID: 25714299 DOI: 10.2214/ajr.14.12885] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
101 Allaire M, Walter A, Sutter O, Nahon P, Ganne-carrié N, Amathieu R, Nault J. TIPS for management of portal-hypertension-related complications in patients with cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2020;44:249-63. [DOI: 10.1016/j.clinre.2019.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
102 Perry BC, Kwan SW. Portosystemic Shunts: Stable Utilization and Improved Outcomes, Two Decades After the Transjugular Intrahepatic Portosystemic Shunt. J Am Coll Radiol 2015;12:1427-33. [PMID: 26410348 DOI: 10.1016/j.jacr.2015.06.037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
103 Charalel RA, Mcginty G, Brant-zawadzki M, Goodwin SC, Khilnani NM, Matsumoto AH, Min RJ, Soares GM, Cook PS. Interventional Radiology Delivers High-Value Health Care and Is an Imaging 3.0 Vanguard. Journal of the American College of Radiology 2015;12:501-6. [DOI: 10.1016/j.jacr.2014.10.024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
104 Fallon MB, Batra S. Inherited thrombophilia and the risk of portal vein thrombosis: progress toward individualized anticoagulation in cirrhosis? Clin Gastroenterol Hepatol 2014;12:1813-4. [PMID: 25086188 DOI: 10.1016/j.cgh.2014.07.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
105 Shiffman ML, Sussman NL, Ravendhran N, Ditmyer M, Kowdley KV, Kugelmas M. Financial Compensation For Hepatologists in Different Practice Settings: Hepatology. Hepatology 2019;69:2664-71. [DOI: 10.1002/hep.30488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
106 Bai M, Qi XS, Yang ZP, Wu KC, Fan DM, Han GH. EVS vs TIPS shunt for gastric variceal bleeding in patients with cirrhosis: A meta-analysis. World J Gastrointest Pharmacol Ther 2014;5:97-104. [PMID: 24868490 DOI: 10.4292/wjgpt.v5.i2.97] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
107 Wu W, He C, Han G. Embolization of spontaneous splenorenal shunt for after-TIPS hepatic encephalopathy in a patient with cirrhosis and variceal bleeding: Wu et al. Hepatology 2015;61:1761-2. [DOI: 10.1002/hep.27438] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
108 Kornerup LS, Gluud LL, Vilstrup H, Dam G. Update on the Therapeutic Management of Hepatic Encephalopathy. Curr Gastroenterol Rep. 2018;20:21. [PMID: 29644492 DOI: 10.1007/s11894-018-0627-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
109 Borentain P, Garcia S, Gregoire E, Vidal V, Ananian P, Ressiot E, Hardwigsen J, Bartoli J, Moulin G, Botta-fridlund D, Le Treut YP, Gerolami R. Transjugular intrahepatic porto-systemic shunt is a risk factor for liver dysplasia but not hepatocellular carcinoma: A retrospective study of explanted livers. Digestive and Liver Disease 2015;47:57-61. [DOI: 10.1016/j.dld.2014.09.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
110 Korsic S, Stabuc B, Skok P, Popovic P. TIPS vs. endoscopic treatment for prevention of recurrent variceal bleeding: a long-term follow-up of 126 patients. Radiol Oncol 2021;55:164-71. [PMID: 33544525 DOI: 10.2478/raon-2021-0006] [Reference Citation Analysis]
111 Jiang Q, Wang MQ, Zhang GB, Wu Q, Xu JM, Kong DR. Transjugular intrahepatic portosystemic shunt combined with esophagogastric variceal embolization in the treatment of a large gastrorenal shunt. World J Hepatol 2016;8:850-7. [PMID: 27458505 DOI: 10.4254/wjh.v8.i20.850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
112 Wang Q, Lv Y, Bai M, Wang Z, Liu H, He C, Niu J, Guo W, Luo B, Yin Z, Bai W, Chen H, Wang E, Xia D, Li X, Yuan J, Han N, Cai H, Li T, Xie H, Xia J, Wang J, Zhang H, Wu K, Fan D, Han G. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. Journal of Hepatology 2017;67:508-16. [DOI: 10.1016/j.jhep.2017.05.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 39] [Article Influence: 15.5] [Reference Citation Analysis]
113 Qi X, Jia J, Bai M, Guo X, Su C, García-Pagán JC, Han G, Fan D. Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding: A Meta-analysis. J Clin Gastroenterol 2015;49:495-505. [PMID: 25127113 DOI: 10.1097/MCG.0000000000000205] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
114 O'leary JG, Orloff SL, Levitsky J, Martin P, Foley DP. Keeping high model for end-stage liver disease score liver transplantation candidates alive: KEEPING LT CANDIDATES ALIVE. Liver Transpl 2015;21:1428-37. [DOI: 10.1002/lt.24329] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
115 Chen H, Turon F, Hernández-Gea V, Fuster J, Garcia-Criado A, Barrufet M, Darnell A, Fondevila C, Garcia-Valdecasas JC, Garcia-Pagán JC. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transpl 2016;22:352-65. [PMID: 26684272 DOI: 10.1002/lt.24387] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
116 Schulman AR, Ryou M, Aihara H, Abidi W, Chiang A, Jirapinyo P, Sakr A, Ajeje E, Ryan MB, Thompson CC. EUS-guided intrahepatic portosystemic shunt with direct portal pressure measurements: a novel alternative to transjugular intrahepatic portosystemic shunting. Gastrointest Endosc. 2017;85:243-247. [PMID: 27468858 DOI: 10.1016/j.gie.2016.07.041] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
117 Gaba RC, Couture PM, Lakhoo J. Gastroesophageal Variceal Filling and Drainage Pathways: An Angiographic Description of Afferent and Efferent Venous Anatomic Patterns. J Clin Imaging Sci. 2015;5:61. [PMID: 26713177 DOI: 10.4103/2156-7514.170730] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
118 Perrin JT, Kennedy CC. 48-Year-Old Man With Dyspnea on Exertion. Mayo Clin Proc 2016;91:509-13. [PMID: 26803352 DOI: 10.1016/j.mayocp.2015.08.025] [Reference Citation Analysis]
119 Tsauo J, Zhao H, Zhang X, Ma H, Jiang M, Weng N, Li X. Effect of Transjugular Intrahepatic Portosystemic Shunt Creation on Pulmonary Gas Exchange in Patients with Hepatopulmonary Syndrome: A Prospective Study. Journal of Vascular and Interventional Radiology 2019;30:170-7. [DOI: 10.1016/j.jvir.2018.09.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
120 Kim SK, Belikoff BG, Guevara CJ, Park SJ. An Algorithm for Management After Transjugular Intrahepatic Portosystemic Shunt Placement According to Clinical Manifestations. Dig Dis Sci. 2017;62:305-318. [PMID: 28058594 DOI: 10.1007/s10620-016-4399-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Ravaioli F, Montagnani M, Lisotti A, Festi D, Mazzella G, Azzaroli F. Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update. Gastroenterol Res Pract 2018;2018:4202091. [PMID: 29977287 DOI: 10.1155/2018/4202091] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
122 Dhaliwal A, Armstrong MJ, Tripathi D. Patient Selection for Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion in Variceal Bleeding and Refractory Ascites. Curr Hepatology Rep 2017;16:241-9. [DOI: 10.1007/s11901-017-0361-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Mekaroonkamol P, Cohen R, Chawla S. Portal hypertensive enteropathy. World J Hepatol. 2015;7:127-138. [PMID: 25729469 DOI: 10.4254/wjh.v7.i2.127] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
124 Andring B, Kalva SP, Sutphin P, Srinivasa R, Anene A, Burrell M, Xi Y, Pillai AK. Effect of technical parameters on transjugular intrahepatic portosystemic shunts utilizing stent grafts. World J Gastroenterol. 2015;21:8110-8117. [PMID: 26185383 DOI: 10.3748/wjg.v21.i26.8110] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
125 Peck-Radosavljevic M, Angermayr B, Datz C, Ferlitsch A, Ferlitsch M, Fuhrmann V, Häfner M, Kramer L, Maieron A, Payer B. Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr. 2013;125:200-219. [PMID: 23579878 DOI: 10.1007/s00508-013-0337-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
126 Fagiuoli S, Bruno R, Debernardi Venon W, Schepis F, Vizzutti F, Toniutto P, Senzolo M, Caraceni P, Salerno F, Angeli P, Cioni R, Vitale A, Grosso M, De Gasperi A, D'Amico G, Marzano A;  AISF TIPS Special Conference. Consensus conference on TIPS management: Techniques, indications, contraindications. Dig Liver Dis. 2017;49:121-137. [PMID: 27884494 DOI: 10.1016/j.dld.2016.10.011] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 10.4] [Reference Citation Analysis]
127 Khan A, Maheshwari S, Gupta K, Naseem K, Chowdry M, Singh S. Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement. J Gastroenterol Hepatol 2021;36:775-81. [PMID: 32710679 DOI: 10.1111/jgh.15194] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Al-Khafaji A, Huang DT. Critical care management of patients with end-stage liver disease. Crit Care Med 2011;39:1157-66. [PMID: 21336121 DOI: 10.1097/CCM.0b013e318211fdc4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
129 Yan X, Fan C, Ma J, Li J, Dong D, Wang H, Ma F, Zheng X, Lv Y. Portacaval shunt established in six dogs using magnetic compression technique. PLoS One 2013;8:e76873. [PMID: 24098809 DOI: 10.1371/journal.pone.0076873] [Reference Citation Analysis]
130 Saab S, Zhao M, Asokan I, Yum JJ, Lee EW. History of Hepatic Encephalopathy Is Not a Contraindication to Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites. Clin Transl Gastroenterol 2021;12:e00378. [PMID: 34333500 DOI: 10.14309/ctg.0000000000000378] [Reference Citation Analysis]
131 Khan F, Armstrong MJ, Mehrzad H, Chen F, Neil D, Brown R, Cain O, Tripathi D. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Aliment Pharmacol Ther. 2019;49:840-863. [PMID: 30828850 DOI: 10.1111/apt.15149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
132 Wang Z, Jiang MS, Zhang HL, Weng NN, Luo XF, Li X, Yang L. Is Post-TIPS Anticoagulation Therapy Necessary in Patients with Cirrhosis and Portal Vein Thrombosis? Radiology. 2016;279:943-951. [PMID: 26653681 DOI: 10.1148/radiol.2015150369] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 8.7] [Reference Citation Analysis]
133 Rössle M. TIPS: 25years later. Journal of Hepatology 2013;59:1081-93. [DOI: 10.1016/j.jhep.2013.06.014] [Cited by in Crossref: 184] [Cited by in F6Publishing: 141] [Article Influence: 23.0] [Reference Citation Analysis]
134 Owen JM, Gaba RC. Transjugular Intrahepatic Portosystemic Shunt Dysfunction: Concordance of Clinical Findings, Doppler Ultrasound Examination, and Shunt Venography. J Clin Imaging Sci. 2016;6:29. [PMID: 27563495 DOI: 10.4103/2156-7514.186510] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
135 Fowler C. Management of patients with complications of cirrhosis. The Nurse Practitioner 2013;38:14-22. [DOI: 10.1097/01.npr.0000427610.76270.45] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
136 Santos S, Dantas E, Veloso Gomes F, Luz JH, Vasco Costa N, Bilhim T, Calinas F, Martins A, Coimbra É. Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension. GE Port J Gastroenterol 2020;28:5-12. [PMID: 33564700 DOI: 10.1159/000507894] [Reference Citation Analysis]
137 Zhou GP, Sun LY, Wei L, Qu W, Zeng ZG, Liu Y, Jiang YZ, Zhu ZJ. Comparision between portosystemic shunts and endoscopic therapy for prevention of variceal re-bleeding: a systematic review and meta-analysis. Chin Med J (Engl) 2019;132:1087-99. [PMID: 30913064 DOI: 10.1097/CM9.0000000000000212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
138 Ditah IC, Al Bawardy BF, Saberi B, Ditah C, Kamath PS. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis. World J Hepatol. 2015;7:1797-1806. [PMID: 26167253 DOI: 10.4254/wjh.v7.i13.1797] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
139 Clark W, Golkar F, Luberice K, Toomey P, Paul H, Marcadis A, Okpaleke C, Vice M, Hernandez J, Alsina A. Uncovering the truth about covered stents: is there a difference between covered versus uncovered stents with transjugular intrahepatic portosystemic shunts? Am J Surg. 2011;202:561-564. [PMID: 21944293 DOI: 10.1016/j.amjsurg.2011.06.021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
140 Heinzow HS, Lenz P, Köhler M, Reinecke F, Ullerich H, Domschke W, Domagk D, Meister T. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis. World J Gastroenterol. 2012;18:5211-5218. [PMID: 23066315 DOI: 10.3748/wjg.v18.i37.5211] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
141 Martens P, Nevens F. Budd-Chiari syndrome. United European Gastroenterol J. 2015;3:489-500. [PMID: 26668741 DOI: 10.1177/2050640615582293] [Cited by in Crossref: 47] [Cited by in F6Publishing: 20] [Article Influence: 7.8] [Reference Citation Analysis]
142 Ni L, Qi R, Zhang LJ, Zhong J, Zheng G, Wu X, Fan X, Lu GM. Brain regional homogeneity changes following transjugular intrahepatic portosystemic shunt in cirrhotic patients support cerebral adaptability theory—A resting-state functional MRI study. European Journal of Radiology 2014;83:578-83. [DOI: 10.1016/j.ejrad.2013.10.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
143 Amodio P. Hepatic encephalopathy. In: Lee SS, Moreau R, editors. Cirrhosis: A practical guide to management. Chichester: John Wiley & Sons, Ltd; 2015. pp. 105-23. [DOI: 10.1002/9781118412640.ch11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
144 Reverter E, Blasi A, Abraldes JG, Martínez-Palli G, Seijo S, Turon F, Berzigotti A, Balust J, Bosch J, García-Pagán JC. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis. Liver Int 2014;34:16-25. [PMID: 23763484 DOI: 10.1111/liv.12229] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
145 Naymagon L. Venous thrombosis of the liver: current and emerging concepts in management. Transl Res 2020;225:54-69. [PMID: 32407789 DOI: 10.1016/j.trsl.2020.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
146 Marini M, Castro-Lopez E, Manteiga DF, Vazquez MA, Soidán DG, Polo JIR, Gómez-Gutiérrez M. Endovascular Treatment of Spleno-Mesenteric-Portal Vein Thrombosis During Orthotopic Liver Transplant: 20 Years Later. Transplant Proc 2020;52:1459-63. [PMID: 32276838 DOI: 10.1016/j.transproceed.2020.02.071] [Reference Citation Analysis]
147 Saugel B, Phillip V, Gaa J, Berger H, Lersch C, Schultheiss C, Thies P, Schneider H, Höllthaler J, Herrmann A, Schmid RM, Huber W. Advanced hemodynamic monitoring before and after transjugular intrahepatic portosystemic shunt: implications for selection of patients--a prospective study. Radiology 2012;262:343-52. [PMID: 22025732 DOI: 10.1148/radiol.11110043] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
148 Fanelli F. The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips. ISRN Hepatol 2014;2014:762096. [PMID: 27335841 DOI: 10.1155/2014/762096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
149 Chen SL, Hu P, Lin ZP, Zhao JB. The Effect of Puncture Sites of Portal Vein in TIPS with ePTFE-Covered Stents on Postoperative Long-Term Clinical Efficacy. Gastroenterol Res Pract. 2019;2019:2935498. [PMID: 30728835 DOI: 10.1155/2019/2935498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
150 Liu J, Zhou B, Chen D, Zhou C, Shi Q, Zheng C, Feng G, Yuan F, Ge Y, Xiong B. Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis. Cardiovasc Intervent Radiol 2019;42:1760-70. [PMID: 31363898 DOI: 10.1007/s00270-019-02295-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
151 Qi X, Han G, Yin Z, He C, Wang J, Guo W, Niu J, Zhang W, Bai M, Fan D. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients. Dig Dis Sci. 2012;57:1072-1082. [PMID: 22147244 DOI: 10.1007/s10620-011-1975-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
152 Nacoti M, Corbella D, Fazzi F, Rapido F, Bonanomi E. Coagulopathy and transfusion therapy in pediatric liver transplantation. World J Gastroenterol. 2016;22:2005-2023. [PMID: 26877606 DOI: 10.3748/wjg.v22.i6.2005] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
153 Loudin M, Ahn J. Portal Vein Thrombosis in Cirrhosis. J Clin Gastroenterol. 2017;51:579-585. [PMID: 28489645 DOI: 10.1097/mcg.0000000000000834] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
154 Bai M, Qi X, Yang Z, Yin Z, Nie Y, Yuan S, Wu K, Han G, Fan D. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol. 2011;26:943-951. [PMID: 21251067 DOI: 10.1111/j.1440-1746.2011.06663.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 73] [Article Influence: 9.7] [Reference Citation Analysis]
155 Bai M, He CY, Qi XS, Yin ZX, Wang JH, Guo WG, Niu J, Xia JL, Zhang ZL, Larson AC, Wu KC, Fan DM, Han GH. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt. World J Gastroenterol. 2014;20:774-785. [PMID: 24574750 DOI: 10.3748/wjg.v20.i3.774] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
156 Coronado WM, Ju C, Bullen J, Kapoor B. Predictors of Occurrence and Risk of Hepatic Encephalopathy After TIPS Creation: A 15-Year Experience. Cardiovasc Intervent Radiol. 2020;43:1156-1164. [PMID: 32435836 DOI: 10.1007/s00270-020-02512-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
157 Raissi D, Yu Q, Nisiewicz M, Krohmer S. Parallel transjugular intrahepatic portosystemic shunt with Viatorr® stents for primary TIPS insufficiency: Case series and review of literature. World J Hepatol 2019;11:217-25. [PMID: 30820271 DOI: 10.4254/wjh.v11.i2.217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
158 Song T, Rössle M, He F, Liu F, Guo X, Qi X. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis. Dig Liver Dis 2018;50:323-30. [PMID: 29422242 DOI: 10.1016/j.dld.2018.01.123] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
159 Wan YM, Li YH, Xu Y, Wu HM, Li YC, Wu XN, Yang JH. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft. Acad Radiol 2018;25:925-34. [PMID: 29373208 DOI: 10.1016/j.acra.2017.11.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
160 Orloff MJ, Vaida F, Haynes KS, Hye RJ, Isenberg JI, Jinich-Brook H. Randomized controlled trial of emergency transjugular intrahepatic portosystemic shunt versus emergency portacaval shunt treatment of acute bleeding esophageal varices in cirrhosis. J Gastrointest Surg 2012;16:2094-111. [PMID: 23007280 DOI: 10.1007/s11605-012-2003-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
161 Pudil R, Praus R, Hulek P, Safka V, Fejfar T, Vasatova M, Jirkovsky V. Transjugular intrahepatic portosystemic shunt is associated with significant changes in mitral inflow parameters. Annals of Hepatology 2013;12:464-70. [DOI: 10.1016/s1665-2681(19)31010-5] [Cited by in Crossref: 9] [Article Influence: 1.1] [Reference Citation Analysis]
162 Qin JP, Jiang MD, Tang W, Wu XL, Yao X, Zeng WZ, Xu H, He QW, Gu M. Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center. World J Gastroenterol. 2013;19:8085-8092. [PMID: 24307804 DOI: 10.3748/wjg.v19.i44.8085] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
163 Cui J, Smolinski SE, Liu F, Xu D, Dulaimy K, Irani Z. Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience. AJR Am J Roentgenol. 2018;210:438-446. [PMID: 29261352 DOI: 10.2214/ajr.17.18222] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
164 Kiamanesh D, Rumley J, Moitra VK. Monitoring and managing hepatic disease in anaesthesia. Br J Anaesth. 2013;111 Suppl 1:i50-i61. [PMID: 24335399 DOI: 10.1093/bja/aet378] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
165 Ferral H, Gomez-Reyes E, Fimmel CJ. Post-Transjugular Intrahepatic Portosystemic Shunt Follow-Up and Management in the VIATORR Era. Tech Vasc Interv Radiol. 2016;19:82-88. [PMID: 26997092 DOI: 10.1053/j.tvir.2016.01.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
166 Funes FR, Silva Rde C, Arroyo PC, Duca WJ, Silva AA, Silva RF. Mortality and complications in patients with portal hypertension who underwent transjugular intrahepatic portosystemic shunt (TIPS) - 12 years experience. Arq Gastroenterol. 2012;49:143-149. [PMID: 22767002 DOI: 10.1590/s0004-28032012000200009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
167 Busk TM, Bendtsen F, Henriksen JH, Fuglsang S, Clemmesen JO, Larsen FS, Møller S. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on blood volume distribution in patients with cirrhosis. Dig Liver Dis 2017;49:1353-9. [PMID: 28729141 DOI: 10.1016/j.dld.2017.06.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
168 Siramolpiwat S. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterol. 2014;20:16996-17010. [PMID: 25493012 DOI: 10.3748/wjg.v20.i45.16996] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 20] [Article Influence: 6.2] [Reference Citation Analysis]
169 Singal AK, Kamath PS, Tefferi A. Mesenteric venous thrombosis. Mayo Clin Proc. 2013;88:285-294. [PMID: 23489453 DOI: 10.1016/j.mayocp.2013.01.012] [Cited by in Crossref: 112] [Cited by in F6Publishing: 52] [Article Influence: 14.0] [Reference Citation Analysis]
170 Wan YM, Li YH, Wu HM, Xu ZY, Xu Y, Yang LH, Wu XN, Yang JH. Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: An observational study (STROBE compliant). Medicine (Baltimore) 2017;96:e8498. [PMID: 29137043 DOI: 10.1097/MD.0000000000008498] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
171 Luo X, Nie L, Tsauo J, Wang Z, Tang C, Li X. Parallel shunt for the treatment of transjugular intrahepatic portosystemic shunt dysfunction. Korean J Radiol. 2013;14:423-429. [PMID: 23690708 DOI: 10.3348/kjr.2013.14.3.423] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
172 Madoff DC, Gaba RC, Weber CN, Clark TW, Saad WE. Portal Venous Interventions: State of the Art. Radiology. 2016;278:333-353. [PMID: 26789601 DOI: 10.1148/radiol.2015141858] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
173 Nielsen MJ, Lehmann J, Leeming DJ, Schierwagen R, Klein S, Jansen C, Strassburg CP, Bendtsen F, Møller S, Sauerbruch T, Karsdal MA, Krag A, Trebicka J. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS. Dig Dis Sci 2015;60:3456-64. [DOI: 10.1007/s10620-015-3783-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
174 Corbett C, Mangat K, Olliff S, Tripathi D. The role of Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) in the management of variceal hemorrhage. Liver Int. 2012;32:1493-1504. [PMID: 22928699 DOI: 10.1111/j.1478-3231.2012.02861.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
175 Spriet I, Meyfroidt G, Maleux G, Verslype C, Willems L. The Impact of a Transjugular Intrahepatic Portosystemic Shunt on the Pharmacokinetics of Caspofungin in a Critically Ill Patient. Pharmacology 2012;90:247-50. [DOI: 10.1159/000342906] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
176 Copelan A, Chehab M, Dixit P, Cappell MS. Safety and efficacy of angiographic occlusion of duodenal varices as an alternative to TIPS: review of 32 cases. Ann Hepatol. 2015;14:369-379. [PMID: 25864218 DOI: 10.1016/s1665-2681(19)31277-3] [Cited by in Crossref: 9] [Article Influence: 1.8] [Reference Citation Analysis]
177 Tsauo J, Shin JH, Han K, Yoon HK, Ko GY, Ko HK, Gwon DI. Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Chylothorax and Chylous Ascites in Cirrhosis: A Case Report and Systematic Review of the Literature. J Vasc Interv Radiol. 2016;27:112-116. [PMID: 26723922 DOI: 10.1016/j.jvir.2015.09.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
178 DellaVolpe J, Al-Khafaji A. Acute Kidney Injury Before and After Liver Transplant. J Intensive Care Med. 2019;34:687-695. [PMID: 30060683 DOI: 10.1177/0885066618790558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
179 Tetangco EP, Silva RG, Lerma EV. Portal hypertension: Etiology, evaluation, and management. Dis Mon 2016;62:411-26. [PMID: 27788916 DOI: 10.1016/j.disamonth.2016.08.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
180 Lee EW, Kuei A, Saab S, Busuttil RW, Durazo F, Han SH, El-Kabany MM, McWilliams JP, Kee ST. Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt. World J Gastroenterol. 2016;22:5780-5789. [PMID: 27433091 DOI: 10.3748/wjg.v22.i25.5780] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
181 Busk TM, Bendtsen F, Møller S. Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis. Eur J Gastroenterol Hepatol. 2013;25:523-530. [PMID: 23325273 DOI: 10.1097/MEG.0b013e32835d09fe] [Cited by in Crossref: 22] [Cited by in F6Publishing: 2] [Article Influence: 2.8] [Reference Citation Analysis]
182 Elfert AA, El-Kalla FS. Gastroenterologists and interventional radiologists: friends or foes? A multidisciplinary approach for solving gastrointestinal problems. Arab J Gastroenterol 2011;12:5-10. [PMID: 21429447 DOI: 10.1016/j.ajg.2011.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
183 Weber CN, Nadolski GJ, White SB, Clark TW, Mondschein JI, Stavropoulos SW, Shlansky-Goldberg RD, Trerotola SO, Soulen MC. Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts. J Vasc Interv Radiol. 2015;26:1257-65; quiz 1265. [PMID: 25990133 DOI: 10.1016/j.jvir.2015.04.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
184 Krajina A, Hulek P, Fejfar T, Valek V. Quality improvement guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS). Cardiovasc Intervent Radiol. 2012;35:1295-1300. [PMID: 23070105 DOI: 10.1007/s00270-012-0493] [Reference Citation Analysis]
185 Das CJ, Soneja M, Tayal S, Chahal A, Srivastava S, Kumar A, Baruah U. Role of radiological imaging and interventions in management of Budd-Chiari syndrome. Clin Radiol 2018;73:610-24. [PMID: 29549997 DOI: 10.1016/j.crad.2018.02.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
186 Bonnel AR, Bunchorntavakul C, Rajender Reddy K. Transjugular intrahepatic portosystemic shunts in liver transplant recipients. Liver Transpl. 2014;20:130-139. [PMID: 24142390 DOI: 10.1002/lt.23775] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
187 Farsad K, Kolbeck KJ. Clinical and Radiologic Evaluation of Patients Before TIPS Creation. American Journal of Roentgenology 2014;203:739-45. [DOI: 10.2214/ajr.14.12999] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
188 Cosarderelioglu C, Cosar AM, Gurakar M, Dagher NN, Gurakar A. Hepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the Literature. J Clin Transl Hepatol 2016;4:47-53. [PMID: 27047772 DOI: 10.14218/JCTH.2015.00044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 3.4] [Reference Citation Analysis]
189 Sundaram SS, Mack CL, Feldman AG, Sokol RJ. Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care. Liver Transpl. 2017;23:96-109. [PMID: 27650268 DOI: 10.1002/lt.24640] [Cited by in Crossref: 89] [Cited by in F6Publishing: 61] [Article Influence: 22.3] [Reference Citation Analysis]
190 Chacko KR, Sigal SH. Update on management of patients with overt hepatic encephalopathy. Hosp Pract (1995) 2013;41:48-59. [PMID: 23948621 DOI: 10.3810/hp.2013.08.1068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
191 Pedersen MR, Molloy P, Wood D, Seetharam A. Direct intrahepatic portocaval shunt for treatment of portal thrombosis and Budd-Chiari syndrome. Ann Hepatol 2016;15:127-30. [PMID: 26626649 DOI: 10.5604/16652681.1184288] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
192 Borentain P, Soussan J, Resseguier N, Botta-Fridlund D, Dufour JC, Gérolami R, Vidal V. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement. Diagn Interv Imaging 2016;97:643-50. [PMID: 26947721 DOI: 10.1016/j.diii.2016.02.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
193 Mellinger JL, Volk ML. Multidisciplinary management of patients with cirrhosis: a need for care coordination. Clin Gastroenterol Hepatol. 2013;11:217-223. [PMID: 23142204 DOI: 10.1016/j.cgh.2012.10.040] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 7.4] [Reference Citation Analysis]
194 Lipnik AJ, Pandhi MB, Khabbaz RC, Gaba RC. Endovascular Treatment for Variceal Hemorrhage: TIPS, BRTO, and Combined Approaches. Semin Intervent Radiol 2018;35:169-84. [PMID: 30087520 DOI: 10.1055/s-0038-1660795] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
195 Moore CM, Van Thiel DH. Cirrhotic ascites review: Pathophysiology, diagnosis and management. World J Hepatol. 2013;5:251-263. [PMID: 23717736 DOI: 10.4254/wjh.v5.i5.251] [Cited by in Crossref: 56] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
196 Luedemann C, Plota J, Nattermann J, Strassburg CP, Lutz P, Goeser F. Renal replacement therapy as bridging-to-recovery in refractory hepatorenal syndrome. Z Gastroenterol 2021;59:331-5. [PMID: 33634437 DOI: 10.1055/a-1369-9859] [Reference Citation Analysis]
197 Busk TM, Bendtsen F, Poulsen JH, Clemmesen JO, Larsen FS, Goetze JP, Iversen JS, Jensen MT, Møgelvang R, Pedersen EB, Bech JN, Møller S. Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis. Am J Physiol Gastrointest Liver Physiol 2018;314:G275-86. [PMID: 29074483 DOI: 10.1152/ajpgi.00094.2017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
198 Merkel C, Montagnese S. Hepatic venous pressure gradient measurement in clinical hepatology. Dig Liver Dis 2011;43:762-7. [PMID: 21549649 DOI: 10.1016/j.dld.2011.03.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
199 Fukui H, Kawaratani H, Kaji K, Takaya H, Yoshiji H. Management of refractory cirrhotic ascites: challenges and solutions. Hepat Med. 2018;10:55-71. [PMID: 30013405 DOI: 10.2147/hmer.s136578] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
200 Carrier P, Debette-gratien M, Essig M, Loustaud-ratti V. Beyond serum creatinine: which tools to evaluate renal function in cirrhotic patients?: Beyond serum creatinine. Hepatol Res 2018;48:771-9. [DOI: 10.1111/hepr.13224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
201 Al-bawardy B, Gorospe EC, Saleem A, Buttar NS, Wong Kee Song LM. Outcomes and Predictors of Rebleeding After 2-Octyl Cyanoacrylate Injection in Acute Gastric Variceal Hemorrhage. Journal of Clinical Gastroenterology 2016;50:458-63. [DOI: 10.1097/mcg.0000000000000487] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
202 Mechler K, Liantonio J. Palliative Care Approach to Chronic Diseases. Primary Care: Clinics in Office Practice 2019;46:415-32. [DOI: 10.1016/j.pop.2019.05.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
203 Hung ML, Lee EW. Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension. Clinics in Liver Disease 2019;23:737-54. [DOI: 10.1016/j.cld.2019.07.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
204 Lombardo S, Espejo JJ, Pérez-Montilla ME, Zurera LJ, González-Galilea Á. The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation. Radiologia (Engl Ed) 2018;60:94-104. [PMID: 29122309 DOI: 10.1016/j.rx.2017.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
205 Catron TD, Smallfield GB, Kang L, Sterling RK, Siddiqui MS. Endoscopic Cyanoacrylate Injection with Post-injection Audible Doppler Assessment of Gastric Varices: A Single-Institution Experience. Dig Dis Sci 2017;62:3091-9. [PMID: 28702754 DOI: 10.1007/s10620-017-4671-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
206 Qi XS, Bai M, Yang ZP, Fan DM. Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review. World J Gastroenterol. 2014;20:6470-6480. [PMID: 24914368 DOI: 10.3748/wjg.v20.i21.6470] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
207 Campos S, Gomes D, Sofia C. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax – a contribution to an unexplored indication: . European Journal of Gastroenterology & Hepatology 2016;28:661-6. [DOI: 10.1097/meg.0000000000000623] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
208 Tong H, Gan C, Wei B, Wang ZD, Li XD, Qian SJ, Huan H, Zhang LH, Yang Z, Chen YL, Gu YH, Chen LX, Yang YH, Wu H, Tang CW. Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis. J Dig Dis 2021;22:31-40. [PMID: 33128287 DOI: 10.1111/1751-2980.12957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
209 Verbeeck S, Mekhali D, Cassiman D, Maleux G, Witters P. Long-term outcome of transjugular intrahepatic portosystemic shunt for portal hypertension in autosomal recessive polycystic kidney disease. Dig Liver Dis 2018;50:707-12. [PMID: 29622386 DOI: 10.1016/j.dld.2018.03.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
210 Jacques J, Carrier P, Debette-gratien M, Sobesky R, Loustaud-ratti V. Encéphalopathie hépatique. La Presse Médicale 2016;45:46-59. [DOI: 10.1016/j.lpm.2015.02.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
211 Liou IW. Management of end-stage liver disease. Med Clin North Am. 2014;98:119-152. [PMID: 24266918 DOI: 10.1016/j.mcna.2013.09.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
212 Spacek LA, Mudalel M, Tittel F, Risby TH, Solga SF. Clinical utility of breath ammonia for evaluation of ammonia physiology in healthy and cirrhotic adults. J Breath Res 2015;9:047109. [PMID: 26658550 DOI: 10.1088/1752-7155/9/4/047109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
213 Seifert LL, Görlich D, Jansen C, Ortmann O, Schoster M, Praktiknjo M, Gu W, Schindler P, Köhler M, Maschmeier M, Wilms C, Meyer C, Schmidt HH, Wildgruber M, Trebicka J, Heinzow H. Evaluation of impact of elective invasive examinations in patients with transjugular intrahepatic portosystemic shunt in the long-term follow up. Z Gastroenterol 2021;59:24-34. [PMID: 33429447 DOI: 10.1055/a-1330-9867] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Moulin B, Chevallier O, Abdulmalak G, Luu M, Latournerie M, Minello A, Gehin S, Cercueil JP, Midulla M, Loffroy R. Persistence of gastric or esophageal varices on final angiography increases transjugular intrahepatic portosystemic shunt revision rate after polytetrafluoroethylene-covered stent shunt creation. Quant Imaging Med Surg 2018;8:174-81. [PMID: 29675358 DOI: 10.21037/qims.2018.03.05] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
215 Hosokawa I, Adam R, Allard M, Pittau G, Vibert E, Cherqui D, Sa Cunha A, Bismuth H, Miyazaki M, Castaing D. Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension. British Journal of Surgery 2017;104:443-51. [DOI: 10.1002/bjs.10431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
216 Parvinian A, Gaba RC. Outcomes of TIPS for Treatment of Gastroesophageal Variceal Hemorrhage. Semin Intervent Radiol. 2014;31:252-257. [PMID: 25177086 DOI: 10.1055/s-0034-1382793] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
217 Bai M, He C, Yin Z, Niu J, Wang Z, Qi X, Liu L, Yang Z, Guo W, Tie J, Bai W, Xia J, Cai H, Wang J, Wu K, Fan D, Han G. Randomised clinical trial: l -ornithine- l -aspartate reduces significantly the increase of venous ammonia concentration after TIPSS. Aliment Pharmacol Ther 2014;40:63-71. [DOI: 10.1111/apt.12795] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
218 Rowe IA, Tripathi D. Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma. Aliment Pharmacol Ther 2015;41:230-230. [DOI: 10.1111/apt.13030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
219 Gómez-Centurión I, Bailén R, Oarbeascoa G, Muñoz C, Luque AÁ, Boyra ME, Calleja E, Rincón D, Dorado N, Barzallo P, Anguita J, Díez-Martín JL, Kwon M. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide. Biol Blood Marrow Transplant 2020;26:2089-97. [PMID: 32791193 DOI: 10.1016/j.bbmt.2020.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
220 Burgos AC, Thornburg B. Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites: Review and Update of the Literature. Semin Intervent Radiol 2018;35:165-8. [PMID: 30087519 DOI: 10.1055/s-0038-1661347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
221 Babineaux MJ, Anand BS. General aspects of the treatment of alcoholic hepatitis. World J Hepatol 2011;3:125-9. [PMID: 21731906 DOI: 10.4254/wjh.v3.i5.125] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
222 Meng J, Wang Q, Liu K, Yang S, Fan X, Liu B, He C, Wu X. Systemic and Splanchnic Lipopolysaccharide and Endothelin-1 Plasma Levels in Liver Cirrhosis before and after Transjugular Intrahepatic Portosystemic Shunt. Gastroenterol Res Pract 2016;2016:8341030. [PMID: 26941788 DOI: 10.1155/2016/8341030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
223 Li YH, Xu ZY, Wu HM, Yang LH, Xu Y, Wu XN, Wan YM. Long-term shunt patency and overall survival of transjugular intrahepatic portosystemic shunt placement using covered stents with bare stents versus covered stents alone. Clin Radiol. 2018;73:580-587. [PMID: 29475551 DOI: 10.1016/j.crad.2018.01.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
224 Bai M, Han G, Qi X, Yin Z, Fan D. Two hypotheses for decreasing hepatic encephalopathy risk after transjugular intrahepatic portosystemic shunt. Hepatology 2010;51:2236-7. [DOI: 10.1002/hep.23493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
225 Becq A, Ozenne V, Plessier A, Valleur P, Dray X. Transjugular intrahepatic portosystemic shunt as bridge-to-surgery in refractory gastric antral vascular ectasia. World J Gastroenterol 2015;21:5749-50. [PMID: 25987803 DOI: 10.3748/wjg.v21.i18.5749] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
226 Armstrong MJ, Gohar F, Dhaliwal A, Nightingale P, Baker G, Greaves D, Mangat K, Zia Z, Karkhanis S, Olliff S, Mehrzad H, Steeds RP, Tripathi D. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis. Aliment Pharmacol Ther 2019;49:797-806. [DOI: 10.1111/apt.15164] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
227 Møller S, Henriksen JH, Bendtsen F. Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects. World J Gastroenterol 2014;20:15499-517. [PMID: 25400435 DOI: 10.3748/wjg.v20.i42.15499] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
228 Simonetto DA, Liu M, Kamath PS. Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clinic Proceedings 2019;94:714-26. [DOI: 10.1016/j.mayocp.2018.12.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 12.5] [Reference Citation Analysis]
229 Grieco S, Sulekova LF, Nardelli S, Riggio O, Venditti M, Taliani G. Portal Hypertension Related to Schistosomiasis Treated With a Transjugular Intrahepatic Portosystemic Shunt. J Clin Gastroenterol 2016;50:608-10. [PMID: 27159422 DOI: 10.1097/MCG.0000000000000545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
230 Shukla A, Bhatt P, Gupta DK, Modi T, Patel J, Phadke M, Rathod K, Meshram M, Bhatia SJ. Cirrhotic cardiomyopathy is less prevalent in patients with Budd-Chiari syndrome than cirrhosis of liver. Indian J Gastroenterol 2017;36:474-80. [PMID: 29368192 DOI: 10.1007/s12664-017-0811-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
231 Young S, Rostambeigi N, Golzarian J, Lim N. MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement. American Journal of Roentgenology 2020;215:215-22. [DOI: 10.2214/ajr.19.21726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
232 Reilly CR, Babushok DV, Martin K, Spivak JL, Streiff M, Bahirwani R, Mondschein J, Stein B, Moliterno A, Hexner EO. Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension. Am J Hematol 2017;92:909-14. [PMID: 28543980 DOI: 10.1002/ajh.24798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
233 American Association for the Study of Liver Diseases. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol. 2014;61:642-659. [PMID: 25015420 DOI: 10.1016/j.jhep.2014.05.042] [Cited by in Crossref: 212] [Cited by in F6Publishing: 145] [Article Influence: 30.3] [Reference Citation Analysis]
234 Morrison JD, Mendoza-elias N, Lipnik AJ, Lokken RP, Bui JT, Ray CE, Gaba RC. Gastric Varices Bleed at Lower Portosystemic Pressure Gradients than Esophageal Varices. Journal of Vascular and Interventional Radiology 2018;29:636-41. [DOI: 10.1016/j.jvir.2017.10.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
235 Parker R, Armstrong MJ, Rowe IA, Houlihan DD. Estimated Short-Term Mortality Following TIPS Insertion for Patients With Hepatic Hydrothorax. American Journal of Gastroenterology 2013;108:1806-7. [DOI: 10.1038/ajg.2013.290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
236 Zheng D, Yu J, Li H, Gan H, Wang J, Jiang T, Ren H, Wu F. Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series. Medicine (Baltimore) 2021;100:e26610. [PMID: 34232216 DOI: 10.1097/MD.0000000000026610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
237 Tacher V, Petit A, Derbel H, Novelli L, Vitellius M, Ridouani F, Luciani A, Rahmouni A, Duvoux C, Salloum C, Chiaradia M, Kobeiter H. Three-dimensional Image Fusion Guidance for Transjugular Intrahepatic Portosystemic Shunt Placement. Cardiovasc Intervent Radiol 2017;40:1732-9. [DOI: 10.1007/s00270-017-1699-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
238 Tsauo J, Li X. Portal vein aneurysm associated with Budd-Chiari syndrome treated with transjugular intrahepatic portosystemic shunt: a case report. World J Gastroenterol 2015;21:2858-61. [PMID: 25759562 DOI: 10.3748/wjg.v21.i9.2858] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
239 Toomey PG, Ross SB, Golkar FC, Hernandez JM, Clark WC, Luberice K, Alsina AE, Rosemurgy AS. Outcomes after transjugular intrahepatic portosystemic stent shunt: a "bridge" to nowhere. Am J Surg 2013;205:441-6. [PMID: 23375760 DOI: 10.1016/j.amjsurg.2012.06.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
240 Horvatits T, Fuhrmann V. Therapeutic options in pulmonary hepatic vascular diseases. Expert Review of Clinical Pharmacology 2013;7:31-42. [DOI: 10.1586/17512433.2014.857598] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
241 Casadaban LC, Parvinian A, Minocha J, Lakhoo J, Grant CW, Ray CE, Knuttinen MG, Bui JT, Gaba RC. Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical Outcomes. Dig Dis Sci. 2015;60:1059-1066. [PMID: 25316553 DOI: 10.1007/s10620-014-3391-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 7.1] [Reference Citation Analysis]
242 Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310-335. [PMID: 27786365 DOI: 10.1002/hep.28906] [Cited by in Crossref: 713] [Cited by in F6Publishing: 475] [Article Influence: 142.6] [Reference Citation Analysis]
243 Pateria P, Jeffrey GP, Garas G, Tibballs J, Ferguson J, Delriviere L, Huang Y, Adams LA, Macquillan G. Transjugular intrahepatic portosystemic shunt: Indications, complications, survival and its use as a bridging therapy to liver transplant in Western Australia. J Med Imaging Radiat Oncol 2017;61:441-7. [DOI: 10.1111/1754-9485.12563] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
244 Salem R, Vouche M, Baker T, Herrero JI, Caicedo JC, Fryer J, Hickey R, Habib A, Abecassis M, Koller F, Vogelzang R, Desai K, Thornburg B, Hohlastos E, Resnick S, Lewandowski RJ, Sato K, Ryu RK, Ganger D, Kulik L. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis. Transplantation. 2015;99:2347-2355. [PMID: 25905983 DOI: 10.1097/tp.0000000000000729] [Cited by in Crossref: 78] [Cited by in F6Publishing: 15] [Article Influence: 15.6] [Reference Citation Analysis]
245 Yan SP, Wu H, Wang GC, Chen Y, Zhang CQ, Zhu Q. A new model combining the liver/spleen volume ratio and classification of varices predicts HVPG in hepatitis B patients with cirrhosis. Eur J Gastroenterol Hepatol. 2015;27:335-343. [PMID: 25563138 DOI: 10.1097/meg.0000000000000269] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
246 Bucher JN, Hollenbach M, Strocka S, Gaebelein G, Moche M, Kaiser T, Bartels M, Hoffmeister A. Segmental intrahepatic cholestasis as a technical complication of the transjugular intrahepatic porto-systemic shunt. World J Gastroenterol 2019;25:6430-9. [PMID: 31798279 DOI: 10.3748/wjg.v25.i43.6430] [Reference Citation Analysis]
247 Shah RP, Sze DY. Complications During Transjugular Intrahepatic Portosystemic Shunt Creation. Techniques in Vascular and Interventional Radiology 2016;19:61-73. [DOI: 10.1053/j.tvir.2016.01.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
248 Shoreibah MG, Mahmoud K, Aboueldahab NA, Vande Lune P, Massoud M, Bae S, El Khudari H, Gunn AJ, Abdel Aal AK. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts. J Vasc Interv Radiol. 2019;30:154-161. [PMID: 30717946 DOI: 10.1016/j.jvir.2018.10.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
249 Qi X, Yang M, Fan D, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures. Scand J Gastroenterol. 2013;48:771-784. [PMID: 23506234 DOI: 10.3109/00365521.2013.777775] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
250 Northup PG, Friedman LS, Kamath PS. AGA Clinical Practice Update on Surgical Risk Assessment and Perioperative Management in Cirrhosis: Expert Review. Clin Gastroenterol Hepatol. 2019;17:595-606. [PMID: 30273751 DOI: 10.1016/j.cgh.2018.09.043] [Cited by in Crossref: 44] [Cited by in F6Publishing: 25] [Article Influence: 14.7] [Reference Citation Analysis]
251 Dunlap R, Golden S, Lyons GR. Portal Vein Aneurysm Treated With Trans-Jugular Intrahepatic Porto-Systemic Shunt. Vasc Endovascular Surg 2021;:15385744211023291. [PMID: 34114524 DOI: 10.1177/15385744211023291] [Reference Citation Analysis]
252 D'Avola D, Bilbao JI, Zozaya G, Pardo F, Rotellar F, Iñarrairaegui M, Quiroga J, Sangro B, Herrero JI. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation. Transplant Proc 2012;44:2603-5. [PMID: 23146469 DOI: 10.1016/j.transproceed.2012.09.050] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
253 De Santis A, Iegri C, Kondili L, Riggio O, Salvatori FM, Catalano C, Di Martino M, Bassanelli C, Lupo M, Lucatelli P, Attili AF. Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: A retrospective case–control study. Digestive and Liver Disease 2014;46:726-30. [DOI: 10.1016/j.dld.2014.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]